Technology And Equipment Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V for the Active Ingredient Vedolizumab

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Interferon Beta-1A (Avonex(R))

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Ingredient Distigmin

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Ingredient Peginterferon Beta-1A

Drug Discount Contracts with Option to Join - 0029-Rvbeitr.62-2023

Open House Drug Discount Agreements Ferric Derisomaltose, Atc B03ac08

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Latanoprost (Edp)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Substance Raltegravir

Open House Drug Rebate Contracts Formoterol, Glycopyrronium Bromide and Budesonide, Atc R03al11

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V for the Active Ingredient Piribedil